Mirum Pharmaceuticals (MIRM) Selling, General & Administrative (2019 - 2026)

Mirum Pharmaceuticals (MIRM) Selling, General & Administrative (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Oculis Holding AG 67,072.09 Bn 67,072.09 Bn - -10.08 Mn
2 Nanobiotix 1,894.61 Bn 1,894.55 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - 2.17 Mn
4 BeOne Medicines 471.64 Bn 466.85 Bn 1.35 Bn 555.10 Mn
5 Vertex Pharmaceuticals 121.72 Bn 114.47 Bn 2.59 Bn 493.70 Mn
6 Regeneron Pharmaceuticals 68.28 Bn 59.52 Bn 3.31 Bn 647.70 Mn
7 Belite Bio 61.40 Bn 61.40 Bn - 17.02 Mn
8 Argenx Se 56.94 Bn 56.94 Bn 1.18 Bn -355.00 Mn
9 Revolution Medicines 37.37 Bn 37.37 Bn - 101.25 Mn
10 Mirum Pharmaceuticals 6.66 Bn 6.27 Bn 131.08 Mn 96.33 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 96.33 Mn
Dec 31, 2025 74.13 Mn
Sep 30, 2025 61.91 Mn
Jun 30, 2025 63.29 Mn
Mar 31, 2025 57.71 Mn
Dec 31, 2024 56.83 Mn
Sep 30, 2024 50.55 Mn
Jun 30, 2024 49.21 Mn
Mar 31, 2024 45.64 Mn
Dec 31, 2023 46.18 Mn
Sep 30, 2023 36.53 Mn
Jun 30, 2023 32.95 Mn
Mar 31, 2023 30.22 Mn
Dec 31, 2022 26.47 Mn
Sep 30, 2022 22.51 Mn
Jun 30, 2022 20.97 Mn
Mar 31, 2022 19.12 Mn
Dec 31, 2021 19.04 Mn
Sep 30, 2021 17.35 Mn
Jun 30, 2021 13.35 Mn